PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
21.68
+0.95 (4.58%)
At close: Aug 21, 2026, 4:00 PM EDT
22.17
+0.49 (2.25%)
After-hours: Aug 21, 2026, 7:30 PM EDT

PROCEPT BioRobotics Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, PROCEPT BioRobotics stock has a consensus rating of "Hold" and an average price target of $21.64. The average 1-year stock price forecast is 0.18% lower than the current stock price, while the lowest is $16 (-26.20%) and the highest is $28 (+29.15%).

Price Target: $21.64 (-0.18%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$16$21.64$21$28
Change-26.20%-0.18%-3.14%+29.15%

Analyst Ratings

The average analyst rating for PROCEPT BioRobotics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy666653
Buy111111
Hold444579
Sell111111
Strong Sell000000
Total121212131414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
William Blair
William Blair
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 9, 2026
Bank of America Securities
Bank of America Securities
Sell
Maintains
n/a
SellMaintainsn/an/aAug 5, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$30$23
BuyMaintains$30$23+6.09%Aug 5, 2026
Truist Financial
Truist Financial
Hold
Reiterates
$25$21
HoldReiterates$25$21-3.14%Aug 5, 2026
UBS
UBS
Hold
Reiterates
$20
HoldReiterates$20-7.75%Aug 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
395.41M
from 308.05M
Increased by 28.36%
Revenue Next Year
476.86M
from 395.41M
Increased by 20.60%
EPS This Year
-1.68
from -1.72
EPS Next Year
-1.15
from -1.68
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
34.47M75.01M136.19M224.50M308.05M395.41M
Revenue Growth
346.72%117.60%81.55%64.84%37.22%28.36%
Gross Profit
15.87M37.09M71.05M137.10M196.23M257.78M
Gross Margin
46.02%49.44%52.17%61.07%63.70%65.19%
Operating Income
-54.16M-80.72M-109.17M-96.61M-103.86M-98.49M
Net Income
-59.85M-87.15M-105.90M-91.41M-95.57M-94.70M
EPS
-----1.72-1.68
Free Cash Flow
-36.81M-53.06M-106.37M-78.24M-23.92M-42.75M
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High402.4M
Avg395.4M
Low384.0M

Revenue Growth

Revenue Growth202620272028
High
30.6%
Avg
28.4%
Low
24.7%

EPS Forecast

EPS202620272028
High-1.62
Avg-1.68
Low-1.82

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-